News
All News
Publications
All PublicationsPharmTechPharmTech Europe
Multimedia
All VideosAsk the ExpertBehind The HeadlinesDrug Digest VideosDrug Solutions Podcast
Conferences
Conference CoverageConference Listing
More
Webcasts
Resources
ICH Q9 Revision: A Comprehensive Resource on Quality Risk ManagementPeer-Reviewed ResearchPharmTech ProductsPharma InsightsSponsored PodcastsSponsored VideosSponsored eBooksWhitepapers

Subscribe

  • News
  • Publications
  • Multimedia
  • Conferences
  • Webcasts
  • Resources
  • Subscribe
  • Analytics
    • Bio/Pharmaceutical Analysis Techniques
    • Laboratory Equipment and Instruments
  • Data and Artificial Intelligence
  • Dosage Forms
    • Solid/Semi-Solid Dosage
    • Specialty Dosage Drugs
    • Parenterals and Injectables
    • Inhalation Drugs
  • Drug Development
    • Intellectual Property and Patents
    • Process and Scaling
    • APIs and Excipients
    • Ingredients
    • Formulation and Drug Delivery
  • Manufacturing
    • Aseptic/Sterile Processing
    • Equipment
    • Process and Automation
    • Manufacturing, Parenterals and Injectables
    • Manufacturing, Biosimilars and Biobetters
    • Manufacturing, Inhalation Drugs
    • Manufacturing, Solid and Semi-Solid Dosage Drugs
    • Manufacturing, Cell Therapies
    • Manufacturing, Biologic Drugs
    • Supply Chain
    • Manufacturing, Gene Therapies
    • Packaging and Distribution
  • Outsourcing
    • Contract Research Services
    • Contract Analytical Services
    • Contract Development Services
    • Regulatory Consulting
    • Logistics and Distribution
    • Contract Manufacturing Services
  • Quality Systems
    • Ask the Expert
    • Quality Assurance/Quality Control
    • Regulatory Oversight and Compliance
Spotlight -
Analytics|
Dosage Forms|
Drug Development|
Manufacturing|
Outsourcing|
Quality Systems
Advertisement

Robert Timpano

Advertisement

Articles by Robert Timpano

Early Development GMPs for Stability (Part IV)

ByQ. Chan Li,Z. Jane Li,Tony Mazzeo,Robert Timpano,Mark Alasandro,Stephen Colgan,Andy Rignall,Z. Jessica Tan,Frank Diana,Bruce Acken,Paul Curry
September 2nd 2012

IQ Consortium representatives explore and define common industry approaches and practices for applying GMPs in early development, with a focus on stability.

Advertisement

Latest Updated Articles

  • Early Development GMPs for Stability (Part IV)
    Early Development GMPs for Stability (Part IV)

    Published: September 2nd 2012 | Updated:



Advertisement
Advertisement

Trending on Pharmaceutical Technology

1

New Dosage Forms and Delivery Systems Driving 505(b)(2) Success

2

PharmTech Weekly News Roundup – Week of November 3, 2025

3

AAPS PharmSci 360: Enhancing Bioanalysis with AI and Other Technologies

4

2025 AAPS PharmSci 360 to Highlight Next-Gen AI for Drug Development

5

How AI, Machine Learning, and Large Language Models Enhance Bioanalysis

  • About Us
  • Advertise
  • Contact Us
  • Editorial Info
  • Editorial Advisory Board
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us